The Supreme Court’s ruling in Riegel v. Medtronic, Inc., may prevent consumers injured by medical devices that have FDA premarket approval from receiving compensation.
An ethical case explores a 70-year-old man diagnosed with pancreatic cancer who wants to have his pacemaker turned off in order to hasten what he fears may be an unpleasant death.